ca1835,3u8895,ca1290,ca4111,www.678mmm.com,masa-c,11aabb.com,友链交换,haha视频,火牛视频

Hepatitis A Preventive Vaccines – Pipeline Assessment And Market Forecasts To 2017-www.cqpx.cc

hanson

Health GlobalData estimated the global hepatitis A preventive vaccines market to be worth $476m in 2010, and it is forecast to grow at 6.2% annually for the next seven years to reach $726m by 2017. This moderate growth is primarily attributed to growth in vaccination coverage due to increases in recommendation for hepatitis A vaccination. The growth is further supported by increases in tourist traffic globally as hepatitis A vaccines are used as traveler vaccines by tourists. However, supply issues with some vaccines act as a barrier to the market. GlobalData analyzed that GlaxoSmithKline and Merck shall remain the leaders in the hepatitis preventive vaccines market. The curnet products display high safe and efficacy profile thereby leaving low unmet need. The supply issues with Mercks brand is taken care of with adequate suppy of GSK vaccines. As a result, the current products are sufficient to meet the current market demands leaving, little scope for new entrants in the near future. The only opportunity for a new entrant lies in developing an oral formulation of hepatitis A vaccine which should improve patient compliance. For Sample Pages, please click or add the below link to your browser: .www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Hepatitis-A-Preventive-Vaccines-Pipeline-Assessment-and-Market-Forecasts-to-2017&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report GlobalData analyzed that the current competition in hepatitis A preventive vaccines market is strong and available treatment options are quite successful in meeting market demand. The products currently in market have displayed high efficacy in terms of almost 100% people being seropositive after vaccination. The products also display a high safely profile with less than 1% of the vaccinated people showing serious side effects. The usage of preventive vaccines has successfully and consistently decreased the incidence of hepatitis A infection. GlobalData, the industry analysis specialist, has released its new report, Hepatitis A Preventive Vaccines Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market and pipeline The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts. For further details, please click or add the below link to your browser: .www.globaldata.com/reportstore/Report.aspx?ID=Hepatitis-A-Preventive-Vaccines-Pipeline-Assessment-and-Market-Forecasts-to-2017&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare Visit our report store: ..globaldata.. For more details contact: [email protected] North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782 About the Author: 相关的主题文章: